Uri Weinberg, Chief Science Officer at NovoCure Ltd (NVCR), sold 6,500 shares at $175.50 ($1.1M) on 2021-02-22, disclosed to the SEC on 2021-02-24.
Open-market sale of $1.1M NVCR by Chief Science Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NVCR | SELL | 2025-03-04 | $5K | — | Filing → |
| NVCR | SELL | 2025-03-03 | $168K | — | Filing → |
| NVCR | SELL | 2023-01-09 | $946K | — | Filing → |